女性化乳房治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2277)
◆英語タイトル:Global Gynecomastia Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2277
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:98
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、女性化乳房治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(医薬品、手術治療)、用途別市場規模(病院薬局、小売薬局、オンライン薬局)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・女性化乳房治療の市場動向
・企業の競争状況、市場シェア
・女性化乳房治療の種類別市場規模(医薬品、手術治療)
・女性化乳房治療の用途別市場規模(病院薬局、小売薬局、オンライン薬局)
・女性化乳房治療の北米市場規模2016-2027(アメリカ、カナダ)
・女性化乳房治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・女性化乳房治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・女性化乳房治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・女性化乳房治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Cadila Pharmaceuticals Ltd、Sun Pharmaceuticals Industries Ltd、Zydus Cadila Healthcare Ltd、Biochem Pharmaceutical Industries Ltd、Dr. Reddy's Laboratories Ltd、Micro Nova Pharmaceuticals Ltd、Kee Pharma Ltd)
・結論
【レポートの概要】

Gynecomastia refers to the proliferation of the glandular tissue in the male breast or the enlargement of the male breast. The major cause of gynecomastia is the hormonal imbalance which occurs between the estrogen level and androgen activity amongst the males. Several medications such as anti-androgens, anti-depressants, etc. are also associated with the cause of gynecomastia. Gynecomastia is common in infancy, puberty and middle-aged. The symptoms of gynecomastia include swelling, nipple discharge, pain, etc. Overuse of herbal products such as tea tree or lavender used in shampoo, soaps, and lotions are also associated with gynecomastia. Based on the product type, the Gynecomastia Treatment market has been segmented into drugs and surgeries. The medications used for the treatment of gynecomastia include tamoxifen, Raloxifene, Aromatase Inhibitors, and other medications.

Market Analysis and Insights: Global Gynecomastia Treatment Market
The global Gynecomastia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gynecomastia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gynecomastia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gynecomastia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gynecomastia Treatment market.

Global Gynecomastia Treatment Scope and Market Size
Gynecomastia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gynecomastia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs
Surgical Treatment

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Cadila Pharmaceuticals Ltd
Sun Pharmaceuticals Industries Ltd
Zydus Cadila Healthcare Ltd
Biochem Pharmaceutical Industries Ltd
Dr. Reddy’s Laboratories Ltd
Micro Nova Pharmaceuticals Ltd
Kee Pharma Ltd

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gynecomastia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Surgical Treatment
1.3 Market by Application
1.3.1 Global Gynecomastia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gynecomastia Treatment Market Perspective (2016-2027)
2.2 Gynecomastia Treatment Growth Trends by Regions
2.2.1 Gynecomastia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gynecomastia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Gynecomastia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Gynecomastia Treatment Industry Dynamic
2.3.1 Gynecomastia Treatment Market Trends
2.3.2 Gynecomastia Treatment Market Drivers
2.3.3 Gynecomastia Treatment Market Challenges
2.3.4 Gynecomastia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gynecomastia Treatment Players by Revenue
3.1.1 Global Top Gynecomastia Treatment Players by Revenue (2016-2021)
3.1.2 Global Gynecomastia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Gynecomastia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gynecomastia Treatment Revenue
3.4 Global Gynecomastia Treatment Market Concentration Ratio
3.4.1 Global Gynecomastia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gynecomastia Treatment Revenue in 2020
3.5 Gynecomastia Treatment Key Players Head office and Area Served
3.6 Key Players Gynecomastia Treatment Product Solution and Service
3.7 Date of Enter into Gynecomastia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gynecomastia Treatment Breakdown Data by Type
4.1 Global Gynecomastia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Gynecomastia Treatment Forecasted Market Size by Type (2022-2027)

5 Gynecomastia Treatment Breakdown Data by Application
5.1 Global Gynecomastia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Gynecomastia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gynecomastia Treatment Market Size (2016-2027)
6.2 North America Gynecomastia Treatment Market Size by Type
6.2.1 North America Gynecomastia Treatment Market Size by Type (2016-2021)
6.2.2 North America Gynecomastia Treatment Market Size by Type (2022-2027)
6.2.3 North America Gynecomastia Treatment Market Size by Type (2016-2027)
6.3 North America Gynecomastia Treatment Market Size by Application
6.3.1 North America Gynecomastia Treatment Market Size by Application (2016-2021)
6.3.2 North America Gynecomastia Treatment Market Size by Application (2022-2027)
6.3.3 North America Gynecomastia Treatment Market Size by Application (2016-2027)
6.4 North America Gynecomastia Treatment Market Size by Country
6.4.1 North America Gynecomastia Treatment Market Size by Country (2016-2021)
6.4.2 North America Gynecomastia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gynecomastia Treatment Market Size (2016-2027)
7.2 Europe Gynecomastia Treatment Market Size by Type
7.2.1 Europe Gynecomastia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Gynecomastia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Gynecomastia Treatment Market Size by Type (2016-2027)
7.3 Europe Gynecomastia Treatment Market Size by Application
7.3.1 Europe Gynecomastia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Gynecomastia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Gynecomastia Treatment Market Size by Application (2016-2027)
7.4 Europe Gynecomastia Treatment Market Size by Country
7.4.1 Europe Gynecomastia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Gynecomastia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gynecomastia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Gynecomastia Treatment Market Size by Type
8.2.1 Asia-Pacific Gynecomastia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gynecomastia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gynecomastia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Gynecomastia Treatment Market Size by Application
8.3.1 Asia-Pacific Gynecomastia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gynecomastia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gynecomastia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Gynecomastia Treatment Market Size by Region
8.4.1 Asia-Pacific Gynecomastia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gynecomastia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gynecomastia Treatment Market Size (2016-2027)
9.2 Latin America Gynecomastia Treatment Market Size by Type
9.2.1 Latin America Gynecomastia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Gynecomastia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Gynecomastia Treatment Market Size by Type (2016-2027)
9.3 Latin America Gynecomastia Treatment Market Size by Application
9.3.1 Latin America Gynecomastia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Gynecomastia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Gynecomastia Treatment Market Size by Application (2016-2027)
9.4 Latin America Gynecomastia Treatment Market Size by Country
9.4.1 Latin America Gynecomastia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Gynecomastia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gynecomastia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Gynecomastia Treatment Market Size by Type
10.2.1 Middle East & Africa Gynecomastia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gynecomastia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gynecomastia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Gynecomastia Treatment Market Size by Application
10.3.1 Middle East & Africa Gynecomastia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gynecomastia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gynecomastia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Gynecomastia Treatment Market Size by Country
10.4.1 Middle East & Africa Gynecomastia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gynecomastia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Cadila Pharmaceuticals Ltd
11.1.1 Cadila Pharmaceuticals Ltd Company Details
11.1.2 Cadila Pharmaceuticals Ltd Business Overview
11.1.3 Cadila Pharmaceuticals Ltd Gynecomastia Treatment Introduction
11.1.4 Cadila Pharmaceuticals Ltd Revenue in Gynecomastia Treatment Business (2016-2021)
11.1.5 Cadila Pharmaceuticals Ltd Recent Development
11.2 Sun Pharmaceuticals Industries Ltd
11.2.1 Sun Pharmaceuticals Industries Ltd Company Details
11.2.2 Sun Pharmaceuticals Industries Ltd Business Overview
11.2.3 Sun Pharmaceuticals Industries Ltd Gynecomastia Treatment Introduction
11.2.4 Sun Pharmaceuticals Industries Ltd Revenue in Gynecomastia Treatment Business (2016-2021)
11.2.5 Sun Pharmaceuticals Industries Ltd Recent Development
11.3 Zydus Cadila Healthcare Ltd
11.3.1 Zydus Cadila Healthcare Ltd Company Details
11.3.2 Zydus Cadila Healthcare Ltd Business Overview
11.3.3 Zydus Cadila Healthcare Ltd Gynecomastia Treatment Introduction
11.3.4 Zydus Cadila Healthcare Ltd Revenue in Gynecomastia Treatment Business (2016-2021)
11.3.5 Zydus Cadila Healthcare Ltd Recent Development
11.4 Biochem Pharmaceutical Industries Ltd
11.4.1 Biochem Pharmaceutical Industries Ltd Company Details
11.4.2 Biochem Pharmaceutical Industries Ltd Business Overview
11.4.3 Biochem Pharmaceutical Industries Ltd Gynecomastia Treatment Introduction
11.4.4 Biochem Pharmaceutical Industries Ltd Revenue in Gynecomastia Treatment Business (2016-2021)
11.4.5 Biochem Pharmaceutical Industries Ltd Recent Development
11.5 Dr. Reddy’s Laboratories Ltd
11.5.1 Dr. Reddy’s Laboratories Ltd Company Details
11.5.2 Dr. Reddy’s Laboratories Ltd Business Overview
11.5.3 Dr. Reddy’s Laboratories Ltd Gynecomastia Treatment Introduction
11.5.4 Dr. Reddy’s Laboratories Ltd Revenue in Gynecomastia Treatment Business (2016-2021)
11.5.5 Dr. Reddy’s Laboratories Ltd Recent Development
11.6 Micro Nova Pharmaceuticals Ltd
11.6.1 Micro Nova Pharmaceuticals Ltd Company Details
11.6.2 Micro Nova Pharmaceuticals Ltd Business Overview
11.6.3 Micro Nova Pharmaceuticals Ltd Gynecomastia Treatment Introduction
11.6.4 Micro Nova Pharmaceuticals Ltd Revenue in Gynecomastia Treatment Business (2016-2021)
11.6.5 Micro Nova Pharmaceuticals Ltd Recent Development
11.7 Kee Pharma Ltd
11.7.1 Kee Pharma Ltd Company Details
11.7.2 Kee Pharma Ltd Business Overview
11.7.3 Kee Pharma Ltd Gynecomastia Treatment Introduction
11.7.4 Kee Pharma Ltd Revenue in Gynecomastia Treatment Business (2016-2021)
11.7.5 Kee Pharma Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 女性化乳房治療の世界市場規模・現状・予測2021年-2027年(Global Gynecomastia Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。